| Identification | Back Directory | [Name]
3,4-MDEA-d5 (hydrochloride) | [CAS]
1286588-92-8 | [Synonyms]
MDE-d5 Hydrochloride
3,4-MDEA-d5 (hydrochloride)
(±)-MDEA-d5 hydrochloride (Ethyl d5)
3,4-MDEA-d5 (hydrochloride) (exempt preparation)
1-(1,3-benzodioxol-5-yl)-N-(1,1,2,2,2-pentadeuterioethyl)propan-2-amine:hydrochloride | [Molecular Formula]
C12H13ClD5NO2 | [MDL Number]
MFCD30718258 | [MOL File]
1286588-92-8.mol | [Molecular Weight]
248.761 |
| Hazard Information | Back Directory | [Description]
3,4-MDEA-d5 (hydrochloride) (exempt preparation) (Item No. 22876) is intended for use as an internal standard for the quantification of 3,4-MDEA (Item Nos. 14085 | ISO60196) by GC- or LC-MS. 3,4-MDEA is categorized as an amphetamine. It has similar psychotropic action to MDMA and shares the common name of "ecstasy". Postmortem findings in human deaths associated with 3,4-MDEA as well as 3,4-MDMA indicate striking brain and myocardial damage as well as liver necrosis. 3,4-MDEA is regulated as a Schedule I compound in the United States. 3,4-MDEA-d5 (hydrochloride) (exempt preparation) (Item No. 22876) is provided as a DEA exempt preparation. This product is intended for research and forensic applications. | [Uses]
1-(1,3-Benzodioxol-5-yl)-N-(1,1,2,2,2-pentadeuterioethyl)propan-2-amine Hydrochloride is used as an internal standard for the quantification of 3,4-MDEA, which has similar psychotropic action to methylenedioxyamphetamine (MDMA) and produces significant retention deficits in learning tasks in rats. | [References]
[1] ROLAND W. FREUDENMANN Manfred S. The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA)[J]. CNS drug reviews, 2006, 10 2: 89-116. DOI: 10.1111/j.1527-3458.2004.tb00007.x
[2] C M MILROY A R F J C Clark. Pathology of deaths associated with “ecstasy” and “eve” misuse.[J]. Journal of Clinical Pathology, 1996, 49 2: 149-153. DOI: 10.1136/jcp.49.2.149 |
|
|